2010 European Society of Hypertension Scientific Meeting , Oslo, Norway, June 2010

Kroon A, Schmidli J, Scheffers I, Tordoir J, Mohaupt M, Allemann Y, Jordan J, Engeli S, Liebeskind U, Luft F, Eckert S, Hansky B, Elletson M , de Leeuw P. , Chronically Implanted System: 4-Year Data of Rheos® DEBuT-HT Study in Patients with Resistant Hypertension. | Presentation

Kroon AA, Bisognanon JD, Bach DS, Kaufman CL, de Leeuw PW. , Baroreflex Activation Therapy® Improves Functional Capacity and Reduces Left Ventricular Mass Index. Results from European and United States Trials of the Rheos® System. Poster |

Bakris G, J. Bisognano J, M. Nadim M, Sanchez L, Sica D, Rheos Pivotal Trial Investigators. , Achievement of Blood Pressure Goal in Patients with Resistant Hypertension Treated with Baroreflex Activation Therapy. Poster |

Interventional Cardiology 2010 25th Annual International Symposium , Snowmass, CO, March 2010

Lovett EG, Little WC. , Baroreflex activation therapy: emerging treatment for hypertension and heart failure | Presentation

2009 American Heart Association Scientific Sessions, Orlando, FL, November 2009

Peter de Leeuw MD, John D. Bisognano MD, David S. Bach MD, Eric G. Lovett PhD, Christopher L. Kaufman PhD, for the DEBuT-HT and Rheos Feasibility Trial Investigators, Improved Myocardial Energetics Following Chronic Treatment Using an Implantable Device in Resistant Hypertension: Results from European and United States Trials of the Rheos® System Poster |

2009 American Society of Nephrology Annual Meeting – Renal Week, San Diego, November 2009

Domenic Sica MD, Marcos Rothstein MD, John D. Bisognano MD, Mitra K. Nadim MD, Eric G. Lovett PhD, Chris Kaufman PhD, Peter de Leeuw MD, for the DEBuT-HT and Rheos Feasibility Investigators, Baroreflex Activation Therapy® Preserves eGFR in Hypertensive Patients with Stage 2 and 3 Chronic Kidney Disease: Results from European and United States Trials of the Rheos® System | Presentation

2009 Heart Failure Society of America Annual Scientific Meeting, Boston, MA, September 2009

John D. Bisognano MD, Peter de Leeuw MD, David S. Bach MD, Eric G. Lovett PhD, Christopher L. Kaufman PhD for the DEBuT and Rheos Feasibility Trial Investigators, Improved Functional Capacity and Cardiovascular Structure After Baroreflex Activation Therapy® in Resistant Hypertension Patients With Symptomatic Heart Failure: Results from European and United States Trials of the Rheos® System Poster |

2009 Transcatheter Cardiovascular Therapeutics Conference , San Francisco, CA, September 2009

Robert S. Kieval, VMD, PhD, Baroreflex Activation Therapy® for the Treatment of Hypertension and Heart Failure | Presentation

2009 European Society of Hypertension Scientific Meeting , Milan, Italy, June 2009

I Scheffers, J Schmidli, A Kroon, J Tordoir, M Mohaupt, Y Allemann, J Jordan, S Engeli, U Liebeskind, FC Luft, S Eckert, B Hansky, T Baal, P de Leeuw, Therapy with a Chronically Implanted System: 3 Year Data from the Rheos DEBuT-HT Study in Patients with Resistant Hypertension | Presentation

2009 American Society of Hypertension Annual Scientific Meeting , San Fransico, CA, May 2009

John D. Bisognano, Peter W. de Leeuw, David S. Bach, Eric G. Lovett, Christopher L. Kaufman, for the DEBuT-HT and Rheos Feasibility Investigators, Baroreflex Hypertension Therapy Improves Cardiac Structure and Arterial Compliance in Resistant Hypertension: Results from European and United States Trials of the Rheos® System | Presentation

2009 Heart Rhythm Society Scientific Sessions, Denver, CO, May 2009

John D. Bisognano, MD, David T. Huang, MD, Christopher L. Kaufman, PhD, for the Rheos Feasibility Trial Investigators, Reduced Arrhythmia Burden in a Resistant Hypertensive Patient Receiving Baroreflex Activation Therapy® from an Implantable Device Poster |

2009 American College of Cardiology Annual Scientific Sessions, Orlando, FL, March 2009

John D. Bisognano, MD, Peter de Leeuw, MD, David S. Bach, MD, Christopher L. Kaufman, PhD, Eric G. Lovett, PhD, for the DEBuT-HT and Rheos Feasibility Trial Investigators, Improved Cardiac Structure and Diastolic Flow Velocities in Early-Stage Heart Failure with Chronic Treatment using an Implantable Device: Results from European and United States Trials of the Rheos® System Poster |